News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Amazon is Considering a $9 Billion Deal to Acquire Satellite Communications Company Globalstar. Here's Why Amazon, Apple, and Tesla Investors Should Pay Attention.2Exxon’s Guyana-Permian Engine Fuels 21% Earnings Growth—Is the 24 P/E Already Discounting a Squeeze?3Bitcoin’s Movement Compared to Oil’s Rally: Evaluating a Risk-Off Scenario
DeNA’s Share Repurchase Is a Protective Move—Not an Indication—While Insiders Remain Inactive
101 finance·2026/04/03 07:15
World Co. Dividend Signal Diverges From Market Doubts—Can the 6.62% Yield Serve as a Real Driver?
101 finance·2026/04/03 07:15
Arzum’s Powerful Technical Surge Encounters Regulatory Uncertainty Amid Pending Investigation
101 finance·2026/04/03 07:12
Tokyo Ohka Grants RSUs Amid Major Buyback—Signaling Skin in the Game or Near-Term Shareholder Conviction?
101 finance·2026/04/03 07:12
Iran Fatalities Exceed 3,200 Amid Escalating Conflict—How Divergent Data Impacts Risk-On and Risk-Off Trading
101 finance·2026/04/03 07:10
Mexedia’s Recovery Accelerates as Digital Growth and Organizational Changes Drive Reduced Losses
101 finance·2026/04/03 07:06
Lilly's Oral GLP-1 Without Restrictions May Challenge Novo's Early Advantage in the Obesity Sector
101 finance·2026/04/03 07:06
Solana Encounters Significant DeFi Breaches and Achieves Key Steps in Regulatory Adoption
101 finance·2026/04/03 07:03
Bambuser at a Crossroads: Will the Costly Shift Lead to Growth or a Standstill?
101 finance·2026/04/03 07:00
Flash
10:35
Investment bank Leerink Partners recently released a research report, initiating coverage on biotechnology company Satellos Bioscience Inc. (stock symbol: MSLE) for the first time.The institution has given the company a positive “Outperform” rating and set a target share price of $20. This rating reflects analysts’ optimistic outlook on the future development prospects of Satellos Bioscience. As a biotechnology company focused on the development of innovative therapies, Satellos Bioscience has attracted market attention with its unique technology platform. Coverage by Leerink Partners will provide investors with professional research references.
10:34
According to the latest filing with the U.S. Securities and Exchange Commission (SEC), Westlake Chemical Corp (WLK) has flexible expansion capacity in its credit financing scale.The document clearly states that the company can increase its existing credit limit to as much as $500 million, with each increment being no less than $25 million. This provision offers significant flexibility for corporate capital management, allowing dynamic adjustments in financing scale based on market conditions and funding needs. The tiered incremental design not only controls financing costs but also ensures the company can seize investment opportunities in a timely manner, demonstrating Westlake’s forward-looking approach to financial strategy.
10:34
Bitcoin rises on news of ceasefire talks between the US and Iran, Algorand surges nearly 50% this monthBitcoin is approaching $70,000 as news of potential ceasefire negotiations between the US and Iran boosts risk appetite, leading to over $270 million in short positions being liquidated. Derivatives data shows increases in open interest for Bitcoin, Ethereum, and several major tokens, with positive funding rates, though the options market remains cautious. Algorand’s ALGO token has surged nearly 50% this month, with its market capitalization surpassing $1 billion, after a Google quantum AI paper mentioned its FALCON post-quantum signature scheme as a model for quantum-secure blockchains.
News